Polyisoprenylated cysteinyl amide inhibitors disrupt actin cytoskeleton organization, induce cell rounding and block migration of non-small cell lung cancerElizabeth Ntantie, Nazarius S. Lamango|Oncotarget|2017Cited by 21
Activation of MAP Kinase Pathway by Polyisoprenylated Cysteinyl Amide Inhibitors Causes Apoptosis and Disrupts Breast Cancer Cell InvasionJassy Mary S. Lazarte, Nazarius S. Lamango|Biomedicines|2024Cited by 5
Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosisMatthew D. Gregory, Nazarius S. Lamango|PLoS ONE|2024Cited by 5
PCAIs stimulate MAPK, PI3K/AKT pathways and ROS-Mediated apoptosis in aromatase inhibitor-resistant breast cancer cells while disrupting actin filaments and focal adhesionJassy Mary S. Lazarte, Nazarius S. Lamango|Oncotarget|2025Cited by 2